Clinical Trial: Effectiveness of a Vaginal Gel on CIN1/2 Regression and HPV Clearance.

U.S., Feb. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07429071) titled 'Effectiveness of a Vaginal Gel on CIN1/2 Regression and HPV Clearance.' on Feb. 09.

Brief Summary: The goal of this clinical trial is to evaluate whether a Coriolus versicolor-based vaginal gel promotes regression of CIN1/CIN2 and facilitates HPV clearance in women aged 30-50 years diagnosed with CIN1 or CIN2 and HPV. In addition, the study will assess patient satisfaction, treatment compliance and characterize the vaginal microbiome.

The primary outcomes therefore is:

* the regression of the cervical dysplasia from baseline to the follow-up (6 months), which will be assessed through either liquid-based cytology and/or histopathol...